These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 16172745)
1. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Lagente V; Manoury B; Nénan S; Le Quément C; Martin-Chouly C; Boichot E Braz J Med Biol Res; 2005 Oct; 38(10):1521-30. PubMed ID: 16172745 [TBL] [Abstract][Full Text] [Related]
2. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Corbel M; Belleguic C; Boichot E; Lagente V Cell Biol Toxicol; 2002; 18(1):51-61. PubMed ID: 11991086 [TBL] [Abstract][Full Text] [Related]
3. Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis. Robert S; Gicquel T; Victoni T; Valença S; Barreto E; Bailly-Maître B; Boichot E; Lagente V Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27247426 [TBL] [Abstract][Full Text] [Related]
4. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis. Manoury B; Nénan S; Guénon I; Lagente V; Boichot E Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192 [TBL] [Abstract][Full Text] [Related]
5. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Manoury B; Caulet-Maugendre S; Guénon I; Lagente V; Boichot E Int J Immunopathol Pharmacol; 2006; 19(3):471-87. PubMed ID: 17026855 [TBL] [Abstract][Full Text] [Related]
7. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737 [TBL] [Abstract][Full Text] [Related]
8. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Lagente V; Le Quement C; Boichot E Expert Opin Ther Targets; 2009 Mar; 13(3):287-95. PubMed ID: 19236151 [TBL] [Abstract][Full Text] [Related]
9. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Belvisi MG; Bottomley KM Inflamm Res; 2003 Mar; 52(3):95-100. PubMed ID: 12755372 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy. Suzuki R; Miyazaki Y; Takagi K; Torii K; Taniguchi H Treat Respir Med; 2004; 3(1):17-27. PubMed ID: 15174890 [TBL] [Abstract][Full Text] [Related]
11. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. Lagente V; Boichot E J Mol Cell Cardiol; 2010 Mar; 48(3):440-4. PubMed ID: 19818795 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Oikonomidi S; Kostikas K; Tsilioni I; Tanou K; Gourgoulianis KI; Kiropoulos TS Curr Med Chem; 2009; 16(10):1214-28. PubMed ID: 19355880 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045 [TBL] [Abstract][Full Text] [Related]
14. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models]. Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602 [TBL] [Abstract][Full Text] [Related]
15. [Proteases involved in airway inflammation of COPD]. Kasagi S; Seyama K; Fukuchi Y Nihon Rinsho; 2003 Dec; 61(12):2113-8. PubMed ID: 14674319 [TBL] [Abstract][Full Text] [Related]
16. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Gueders MM; Foidart JM; Noel A; Cataldo DD Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964 [TBL] [Abstract][Full Text] [Related]
18. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis. Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Lappalainen U; Whitsett JA; Wert SE; Tichelaar JW; Bry K Am J Respir Cell Mol Biol; 2005 Apr; 32(4):311-8. PubMed ID: 15668323 [TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease. Navratilova Z; Kolek V; Petrek M Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):177-93. PubMed ID: 26611761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]